Skip to main content
Article thumbnail
Location of Repository

Effect of Nanoparticles on Protein Folding and Fibrillogenesis

By Li Fei and Sarah Perrett


The large surface area and small size of nanoparticles provide properties and applications that are distinct from those of bulk materials. The ability of nanoparticles to influence protein folding and aggregation is interesting, not only because of the potential beneficial applications, but also the potential risks to human health and the environment. This makes it essential that we understand the effect of nanoparticles on fundamental biological process, like protein folding. Here, we review studies that have examined the effect of nanoparticles on protein folding and aggregation, providing insight both into the mechanisms of these processes and how they may be controlled

Topics: Review
Publisher: Molecular Diversity Preservation International (MDPI)
OAI identifier:
Provided by: PubMed Central

Suggested articles


  1. (2008). Brain permeable nanoparticles. Recent Patents CNS Drug Discov.
  2. (2008). Characterization of secondary and tertiary conformational changes of beta-lactoglobulin adsorbed on silica nanoparticle surfaces. Langmuir
  3. Dendrimer effects on peptide and protein fibrillation.
  4. (2007). Detailed identification of plasma proteins adsorbed on copolymer nanoparticles.
  5. (2007). Direct conjugation of semiconductor nanocrystals to a globular protein to study protein-folding intermediates.
  6. (2008). Drug delivery and nanoparticles: applications and hazards.
  7. (2008). Effect of surface concentration on secondary and tertiary conformational changes of lysozyme adsorbed on silica nanoparticles.
  8. (2008). Emerging and potential therapies for Alzheimer's disease. Expert Opin. Ther. Targets
  9. (2008). Folding induced assembly of polypeptide decorated gold nanoparticles.
  10. (2003). Fullerene inhibits beta-amyloid peptide aggregation.
  11. Immunological properties of engineered nanomaterials.
  12. (2008). Influence of fluorinated and hydrogenated nanoparticles on the structure and fibrillogenesis of amyloid beta-peptide.
  13. (2008). Inhibition of amyloid beta protein fibrillation by polymeric nanoparticles.
  14. (2006). Inhibition of the formation of amyloid beta-protein fibrils using biocompatible nanogels as artificial chaperones. FEBS Lett.
  15. Intrinsic peroxidase-like activity of ferromagnetic nanoparticles.
  16. (2008). Magnetic nanoparticles for gene and drug delivery.
  17. (1999). Molecular chaperone-like activity of hydrogel nanoparticles of hydrophobized pullulan: Thermal stabilization with refolding of carbonic anhydrase
  18. (2007). Nanoparticles as catalysts for protein fibrillation.
  19. Nanotechnology applications in cancer.
  20. (2008). New aspects of nanopharmaceutical delivery systems.
  21. (2007). Nucleation of protein fibrillation by nanoparticles.
  22. Pathways of chaperone-mediated protein folding in the cytosol.
  23. (2006). PEGylated phospholipid nanomicelles interact with beta-amyloid((1-42)) and mitigate its beta-sheet formation, aggregation and neurotoxicity in vitro. Peptides
  24. (2008). Peptide-based nanoparticle for ex vivo and in vivo drug
  25. (2007). pH-Dependent protein conformational changes in albumin: Gold nanoparticle bioconjugates: A spectroscopic study. Langmuir
  26. (2008). Photothermal ablation of amyloid aggregates by gold nanoparticles. Colloids Surf.
  27. (2003). Protein refolding assisted by self-assembled nanogels as novel artificial molecular chaperone. FEBS Lett.
  28. (2004). Roles of heat-shock chaperones in the production of recombinant proteins in Escherichia coli.
  29. (2004). Silica nanoparticle size influences the structure and enzymatic activity of adsorbed lysozyme. Langmuir
  30. (2002). Structure and function of the GroE chaperone. Cell Mol. Life Sci.
  31. (2008). Synthetic "chaperones": nanoparticle-mediated refolding of thermally denatured proteins.
  32. (2007). The growing need for in vivo study.
  33. (2007). The workings of the amyloid diseases.
  34. (2008). TiO2 nanoparticles promote beta-amyloid fibrillation in vitro.
  35. (2006). Toxic potential of materials at the nanolevel. Science
  36. (2007). Understanding the nanoparticle-protein corona using methods to quantify exchange rates and affinities of proteins for nanoparticles.
  37. (2007). Unfolding of ribonuclease A on silica nanoparticle surfaces. Nano Lett.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.